Human Parechoviruses as an Important Viral Cause of Sepsislike Illness and Meningitis in Young Children
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Enteroviruses (EVs) belong to the family Picornaviridae and are a well-known cause of neonatal sepsis and viral meningitis. Human parechoviruses (HPeVs) type 1 and 2, previously named echovirus 22 and 23, have been associated with mild gastrointestinal or respiratory symptoms in young children. Six HPeV genotypes are currently known, of which HPeV3 is associated with neonatal sepsis and meningitis. METHODS: Cerebrospinal fluid samples from children aged <5 years previously tested by EV-specific polymerase chain reaction (PCR) during 2004-2006 were selected (N= 761). Samples from 716 of those children were available for retrospective testing by HPeV-specific real-time PCR. The prevalence of EV and HPeV in these samples was compared. Data on clinical presentation of children infected with HPeV were retrospectively documented. RESULTS: HPeV was found in cerebrospinal fluid samples from 33 (4.6%) of the children. Yearly prevalence of HPeV in cerebrospinal fluid varied remarkably: 8.2% in 2004, 0.4% in 2005, and 5.7% in 2006. EV was detected in 14% (108 of 761 samples), with no variation in yearly prevalence. Children with HPeV in cerebrospinal fluid presented with clinical symptoms of sepsislike illness and meningitis, which led to hospitalization and antibiotic treatment. CONCLUSION: EV-specific PCRs do not detect HPeVs. The addition of an HPeV-specific PCR has led to a 31% increase in detection of a viral cause of neonatal sepsis or central nervous system symptoms in children aged <5 years. HPeV can be considered to be the second cause of viral sepsis and meningitis in young children, and rapid identification of HPeV by PCR could contribute to shorter duration of both antibiotic use and hospital stay.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HPeV-3 is the HPeV type that is most commonly associated with viral meningitis [79].”
From Viral meningitis: an overview (2021) · cites this paper as [79]
In the citing paper
“Sepsis-like syndrome has been reported in 40–80% of HPeV (especially type 3) infections and 10–30% of EV infections in young infants (21–27).”
From Epidemiology of pediatric meningitis and encephalitis in Japan: a cross-sectional study (2024) · cites this paper as [22]
In the citing paper
“In children aged <3 months, approximately 90% of those with HPeV-positive CSF and >50% of those with EV-positive CSF showed normal CSF cell counts, consistent with previous reports' results (21–25).”
From Epidemiology of pediatric meningitis and encephalitis in Japan: a cross-sectional study (2024) · cites this paper as [22]
In the citing paper
“Human enteroviruses (EV) and parechovirus (HPeV) belong to the highly diversified family Picornaviridae and constitute an important cause of central nervous system (CNS) infections, meningitis and encephalitis, and sepsis-like illness in children worldwide [1–3].”
Citations
Cites
Rapid and simple method for purification of nucleic acids
Boom, R., Sol, C. J., Salimans, M. M., Jansen, C. L., Wertheim-van Dillen, P. M., & van der Noordaa, J. (1990) · Journal of Clinical Microbiology · doi:10.1128/jcm.28.3.495-503.1990 · Cited by 5,266 · cited 1×
“[22], with use of 20 mL of sizefractionated silica particles in combination with 900 mL of lysis buffer L6.”
MethodMellor, D. H. (1981) · Cited by 1,981
(1995) · ASM Press eBooks · doi:10.1128/9781555818326 · Cited by 337
Enteroviruses in human disease.
Grist, N. R., Ej, B., & Assaad, F. A. (1978) · PubMed · Cited by 293
Benschop, K. S. M., Schinkel, J., Minnaar, R. P., Pajkrt, D., Spanjerberg, L., Kraakman, H. C., Berkhout, B., Zaaijer, H. L., Beld, M. G. H. M., & Wolthers, K. C. (2006) · Clinical Infectious Diseases · doi:10.1086/498905 · Cited by 261 · cited 3×
“Genotyping of HPeV can be done by sequencing of the VP1 gene [6, 12], but this has been performed only on HPeV isolates obtained from cell culture.”
BackgroundSelf-citationIsolation and identification of a novel human parechovirus
Ito, M., Yamashita, T., Tsuzuki, H., Takeda, N., & Sakae, K. (2004) · Journal of General Virology · doi:10.1099/vir.0.19456-0 · Cited by 257 · cited 1×
“Recent studies of HPeV3 all show an association with more-severe disease than HPeV1 infection—that is, neonatal sepsis, meningitis, and paralysis [4, 7, 12, 16].”
BackgroundPolymerase Chain Reaction for Human Picornaviruses
Hyypia, T., Auvinen, P., & Maaronen, M. (1989) · Journal of General Virology · doi:10.1099/0022-1317-70-12-3261 · Cited by 227 · cited 1×
“Human Parechoviruses in CSF • CID 2008:47 (1 August) • 359 5′ end of the genome [19, 20].”
BackgroundHuman Parechovirus 3 and Neonatal Infections
Boivin, G., Abed, Y., & Boucher, F. D. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1101.040606 · Cited by 199 · cited 1×
“sis and meningitis [11, 12].”
Human parechoviruses?biology and clinical significance
Stanway, G., Joki-Korpela, P., & Hyypi�, T. (2000) · Reviews in Medical Virology · doi:10.1002/(sici)1099-1654(200001/02)10:1<57::aid-rmv266>3.0.co;2-h · Cited by 169 · cited 2×
“HPeV1 is considered to be a widely spread pathogen that affects mainly young children [8, 9].”
BackgroundIsolation and Characterization of Novel Human Parechovirus from Clinical Samples
Watanabe, K., Oie, M., Higuchi, M., Nishikawa, M., & Fujii, M. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1306.060896 · Cited by 152 · cited 2×
“However, different HPeV genotypes might circulate in different years or seasons, as has been suggested elsewhere [7, 10, 12, 29].”
Background
Research works printed but not linked: 2
- King AMQ, Brown F, Christian P, etal Picornaviridae. In: Van Regenmortel MHV, Fauquet CM, Calisher CH, et al., eds. Virus taxonomy: classification and nomenclature of viruses. Seventh Report of the ICTV. New York: Academic Press, 2000; 657-673.
- Grist NR, 1978, Prog Med Virol, 24, 114
Cited by
Simonsen, K. A., Anderson-Berry, A. L., Delair, S. F., & Davies, H. D. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00031-13 · Cited by 984
“(99) reported that addition of a HPeV-specific PCR to CSF tests conducted on 761 children 5 years of age (46% of whom were neonates) led to a 31% increase in detection of a viral cause of neonatal sepsis or central nervous system symptoms, suggesting that they are underdiagnosed.”
BackgroundInfluentialEpidemiology and Immune Pathogenesis of Viral Sepsis
Lin, G.-L., McGinley, J. P., Drysdale, S. B., & Pollard, A. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02147 · Cited by 351
“Herpes simplex virus (HSV) and enteroviruses are the most common viral causes of neonatal sepsis (32), while enteroviruses and human parechoviruses (HPeVs) are the most common causes of viral sepsis in young children (33).”
BackgroundMethodInfluentialNeurotropic virus infections as the cause of immediate and delayed neuropathology
Ludlow, M., Kortekaas, J., Herden, C., Hoffmann, B., Tappe, D., Trebst, C., Griffin, D. E., Brindle, H. E., Solomon, T., Brown, A. S., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1511-3 · Cited by 317
“Following EVs, the second most frequent viral cause of CNS disease is HPeV [143], which belongs to the Parechovirus genus.”
BackgroundSelf-citationHuman enterovirus 71 and hand, foot and mouth disease
WONG, S. S. Y., YIP, C. C. Y., LAU, S. K. P., & YUEN, K. Y. (2010) · Epidemiology and Infection · doi:10.1017/s0950268809991555 · Cited by 247
Epidemiology and Clinical Associations of Human Parechovirus Respiratory Infections
Harvala, H., Robertson, I., McWilliam Leitch, E. C., Benschop, K., Wolthers, K. C., Templeton, K., & Simmonds, P. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01207-08 · Cited by 213
Self-citationHuman parechoviruses: Biology, epidemiology and clinical significance
Harvala, H., & Simmonds, P. (2009) · Journal of Clinical Virology · doi:10.1016/j.jcv.2009.03.009 · Cited by 198
Enterovirus and parechovirus infection in children: a brief overview
de Crom, S. C. M., Rossen, J. W. A., van Furth, A. M., & Obihara, C. C. (2016) · European Journal of Pediatrics · doi:10.1007/s00431-016-2725-7 · Cited by 192
“Besides being more sensitive, it is also easier and more rapid to perform than viral culture [28, 53, 69, 70].”
BackgroundBenschop, K., Thomas, X., Serpenti, C., Molenkamp, R., & Wolthers, K. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01379-08 · Cited by 167
“Human parechovirus 1 (HPeV1) and HPeV2 were first identified in the mid-1960s as human enteroviruses (HEVs) and were classified as echovirus 22 and 23 (30).”
ResultSelf-citationKohil, A., Jemmieh, S., Smatti, M. K., & Yassine, H. M. (2021) · Archives of Virology · doi:10.1007/s00705-020-04891-1 · Cited by 164
Replication and Inhibitors of Enteroviruses and Parechoviruses
van der Linden, L., Wolthers, K. C., & van Kuppeveld, F. J. M. (2015) · Viruses · doi:10.3390/v7082832 · Cited by 181
“HPeVs are the second most important cause of viral sepsis-like illness and meningitis in infants [32–34].”
BackgroundSelf-citationHuman Parechovirus: an Increasingly Recognized Cause of Sepsis-Like Illness in Young Infants
Olijve, L., Jennings, L., & Walls, T. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00047-17 · Cited by 159
“complications in infants who are severely affected (5, 10, 13).”
BackgroundInfluentialParechovirus Encephalitis and Neurodevelopmental Outcomes
Britton, P. N., Dale, R. C., Nissen, M. D., Crawford, N., Elliott, E., Macartney, K., Khandaker, G., Booy, R., Jones, C. A., & on behalf of the PAEDS-ACE Investigators (2016) · Pediatrics · doi:10.1542/peds.2015-2848 · Cited by 144
Enterovirus infections in neonates
Tebruegge, M., & Curtis, N. C. (2009) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2009.02.002 · Cited by 158
Parechoviruses in children: understanding a new infection
Harvala, H., Wolthers, K. C., & Simmonds, P. (2010) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32833890ca · Cited by 138
Self-citationTan, L. V., Qui, P. T., Ha, D. Q., Hue, N. B., Bao, L. Q., Cam, B. V., Khanh, T. H., Hien, T. T., Vinh Chau, N. V., Tram, T. T., et al. (2010) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000854 · Cited by 129
“As a previous report suggested that human parechovirus infections exhibit a two-yearly incidence peak [33], the absence of parechovirus infections in our patients may be due to the fact that our study period covered only one year.”
ResultPediatric parechovirus infections
Esposito, S., Rahamat-Langendoen, J. C., Ascolese, B., Senatore, L., Castellazzi, L., & Niesters, H. G. M. (2014) · Journal of Clinical Virology · doi:10.1016/j.jcv.2014.03.003 · Cited by 125
Human Parechovirus 3 Causing Sepsis-like Illness in Children From Midwestern United States
Selvarangan, R., Nzabi, M., Selvaraju, S. B., Ketter, P., Carpenter, C., & Harrison, C. J. (2011) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181fbefc8 · Cited by 120
“Most of our patients with detectable HPeV CNS infections were predominantly males 2 months of age similar to the predominantly 3 months of age noted in the United Kingdom and Dutch reports.(6) Studies from Europe and South America have noted more overt neurologic signs (febrile seizures or even acute flaccid paralysis…”
BackgroundResultInfluentialDolin, H. H., Papadimos, T. J., Chen, X., & Pan, Z. K. (2019) · Microbiology Insights · doi:10.1177/1178636118825081 · Cited by 146
Sepsis-like Disease in Infants Due to Human Parechovirus Type 3 During an Outbreak in Australia
Khatami, A., McMullan, B. J., Webber, M., Stewart, P., Francis, S., Timmers, K. J., Rodas, E., Druce, J., Mehta, B., Sloggett, N. A., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu784 · Cited by 119
“Our series has a less marked male preponderance (55%) than previously reported [7, 10, 13, 16].”
BackgroundResultInfluentialNovel Human Parechovirus from Brazil
Drexler, J. F., Grywna, K., Stöcker, A., Almeida, P. S., Ribeiro, T. C. M., Eschbach-Bludau, M., Petersen, N., Ribeiro, H. D. C., & Drosten, C. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1502.081028 · Cited by 117
“Phylogenetic segregation from all known HPeVs was obvious not only in VP1 but also along the structural proteins VP0 and VP3 (aa identities with established HPeV types ranges 71.2%– 80.2% in VP0 and 74.1%–80.0% in VP3) (Figure 1).”
BackgroundMethodInfluentialHarvala, H., McLeish, N., Kondracka, J., McIntyre, C. L., McWilliam Leitch, E. C., Templeton, K., & Simmonds, P. (2011) · Journal of Medical Virology · doi:10.1002/jmv.22023 · Cited by 112
“Although HPeV infections are common and the clinical course is usually mild, theyhavebeen recently associatedwith sepsis-like disease in very young children [Boivin et al., 2005; Wolthers et al., 2008; Harvala et al., 2009].”
BackgroundInfiltrating Macrophages Are Key to the Development of Seizures following Virus Infection
Cusick, M. F., Libbey, J. E., Patel, D. C., Doty, D. J., & Fujinami, R. S. (2013) · Journal of Virology · doi:10.1128/jvi.02747-12 · Cited by 112
“A recent retrospective study, using pediatric cerebrospinal fluid samples previously screened for EV, demonstrated that the inclusion of a novel PeV-specific PCR assay led to a 31% increase in the detection of viruses causing virally induced CNS symptoms and neonatal sepsis (4).”
Benschop, K., Minnaar, R., Koen, G., van Eijk, H. W. M., Dijkman, K., Westerhuis, B. M., Molenkamp, R., & Wolthers, K. C. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.05.016 · Cited by 103
“The classic method for diagnosis of infection with HEVs or HPeVs has been virus isolation by cell culture from stool samples, throat swabs, cerebral spinal fluid (CSF), and blood.”
MethodSelf-citationPicornavirus non-structural proteins as targets for new anti-virals with broad activity
Norder, H., Palma, A. M. D., Selisko, B., Costenaro, L., Papageorgiou, N., Arnan, C., Coutard, B., Lantez, V., de Lamballerie, X. N., Baronti, C., et al. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2010.12.007 · Cited by 89
Harvala, H., Calvert, J., Van Nguyen, D., Clasper, L., Gadsby, N., Molyneaux, P., Templeton, K., McWilliams Leitch, C., & Simmonds, P. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.15.20772 · Cited by 87
“To identify potential global spread, surveillance in the UK and elsewhere in Europe is essential, including testing of community-collected samples as recently carried out in France as part of large prospective observational study [19].”
ResultInfluentialHuman parechovirus infections, Lyon, France, 2008–10: Evidence for severe cases
Schuffenecker, I., Javouhey, É., Gillet, Y., Kugener, B., Billaud, G., Floret, D., Lina, B., & Morfin, F. (2012) · Journal of Clinical Virology · doi:10.1016/j.jcv.2012.04.016 · Cited by 85
Comprehensive full-length sequence analyses of human parechoviruses: diversity and recombination
Benschop, K. S. M., de Vries, M., Minnaar, R. P., Stanway, G., van der Hoek, L., Wolthers, K. C., & Simmonds, P. (2010) · Journal of General Virology · doi:10.1099/vir.0.014670-0 · Cited by 83
“Clinical studies have indicated HPeV3 as the predominant type associated with severe symptoms in neonates and as the main type infecting the central nervous system (Benschop et al., 2008a; Verboon-Maciolek et al., 2008; Wolthers et al., 2008).”
Self-citationHUMAN PARECHOVIRUS-3 INFECTION: EMERGING PATHOGEN IN NEONATAL SEPSIS
Levorson, R. E., Jantausch, B. A., Wiedermann, B. L., Spiegel, H. M. L., & Campos, J. M. (2009) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318194596a · Cited by 73
Human Parechovirus Infection, Denmark
Fischer, T. K., Midgley, S., Dalgaard, C., & Nielsen, A. Y. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2001.130569 · Cited by 70
Harvala, H., Griffiths, M., Solomon, T., & Simmonds, P. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.02.017 · Cited by 69
Characteristics and outcomes of human parechovirus infection in infants (2008–2012)
Vergnano, S., Kadambari, S., Whalley, K., Menson, E., Martinez-Alier, N., Cooper, M. K., Sanchez, E., Heath, P. T., & Lyall, H. (2015) · European Journal of Pediatrics · doi:10.1007/s00431-014-2483-3 · Cited by 70
Clinical Characteristics of Human Parechoviruses 4–6 Infections in Young Children
Pajkrt, D., Benschop, K. S. M., Westerhuis, B., Molenkamp, R., Spanjerberg, L., & Wolthers, K. C. (2009) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181a7ab5f · Cited by 71
“It is well known that EV can cause sepsis-like illness and aseptic meningitis in young children(1,24) and recently we demonstrated that patients with HPeV in the CSF presented with sepsis-like illness and meningitis.(22) HPeV3 infections are associated with more severe disease such as neonatal sepsis and meningitis, e…”
BackgroundMethodResultSelf-citationWesterhuis, B. M., Koen, G., Wildenbeest, J. G., Pajkrt, D., de Jong, M. D., Benschop, K. S. M., & Wolthers, K. C. (2012) · Journal of General Virology · doi:10.1099/vir.0.043323-0 · Cited by 64
“C H A P T E R 3 40 C H A P T E R 3 In addition to differences in clinical symptoms, children infected with HPeV3 are significantly younger (<2 months) than children infected with HPeV1 (>6 months) (Benschop et al., 2006a; Wolthers et al., 2008).”
BackgroundSelf-citationHuman parechoviruses are frequently detected in stool of healthy Finnish children
Kolehmainen, P., Oikarinen, S., Koskiniemi, M., Simell, O., Ilonen, J., Knip, M., Hyöty, H., & Tauriainen, S. (2012) · Journal of Clinical Virology · doi:10.1016/j.jcv.2012.02.006 · Cited by 62
Walters, B., Peñaranda, S., Nix, W. A., Oberste, M. S., Todd, K. M., Katz, B. Z., & Zheng, X. (2011) · Journal of Clinical Virology · doi:10.1016/j.jcv.2011.07.008 · Cited by 60
Human parechovirus type 3 infection: An emerging infection in neonates and young infants
Aizawa, Y., Izumita, R., & Saitoh, A. (2017) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2017.04.009 · Cited by 60
“HPeV3 causes severe disease in neonates and infants younger than 3 months, including sepsis-like symptoms and sepsis [7,31], meningitis [8], and encephalitis [38e43].”
BackgroundResultBarber, R. M., Porter, B. F., Li, Q., May, M. A., Claiborne, M. K., Allison, A. B., Howerth, E. W., Butler, A., Wei, S., Levine, J. M., et al. (2012) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2012.00954.x · Cited by 60
Role of Maternal Antibodies in Infants with Severe Diseases Related to Human Parechovirus Type 31
Aizawa, Y., Watanabe, K., Oishi, T., Hirano, H., Hasegawa, I., & Saitoh, A. (2015) · Emerging infectious diseases · doi:10.3201/eid2111.150267 · Cited by 58
“HPeV3 infection can be accompanied by sepsis-like syndrome (10,11), which can lead to neurologic sequelae (12) and death (13), and has therefore attracted pediatricians’ attention (14).”
BackgroundHuman Parechovirus 3 Meningitis and Fatal Leukoencephalopathy
Bissel, S. J., Auer, R. N., Chiang, C.-H., Kofler, J., MURDOCH, G. H., Nix, W. A., Painter, M. J., Richer, M., Sartelet, H., Wang, G., et al. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000215 · Cited by 57
The Human Parechoviruses: An Overview
Romero, J. R., & Selvarangan, R. (2011) · Advances in Pediatrics · doi:10.1016/j.yapd.2011.03.008 · Cited by 57
Piralla, A., Mariani, B., Stronati, M., Marone, P., & Baldanti, F. (2014) · Early Human Development · doi:10.1016/s0378-3782(14)70023-4 · Cited by 57
“Recently, it has been shown that HPeV genotype 3 is an important cause of severe infections, including sepsis-like illness and encephalitis in newborns [4–7].”
Successful IVIG Treatment of Human Parechovirus-Associated Dilated Cardiomyopathy in an Infant
Wildenbeest, J. G., Wolthers, K. C., Straver, B., & Pajkrt, D. (2013) · Pediatrics · doi:10.1542/peds.2012-1136 · Cited by 55
Self-citationAizawa, Y., Suzuki, Y., Watanabe, K., Oishi, T., & Saitoh, A. (2015) · Journal of Infection · doi:10.1016/j.jinf.2015.10.010 · Cited by 55
Parechovirus A Pathogenesis and the Enigma of Genotype A-3
Sridhar, A., Karelehto, E., Brouwer, L., Pajkrt, D., & Wolthers, K. C. (2019) · Viruses · doi:10.3390/v11111062 · Cited by 59
“Central nervous system (CNS) syndromes such as acute flaccid paralysis, meningitis, and encephalitis have been reported for PeV-A1 and A3 [2,4,25,101].”
BackgroundSelf-citationEvolution and conservation in human parechovirus genomes
Williams, Ç. H., Panayiotou, M., Girling, G. D., Peard, C. I., Oikarinen, S., Hyöty, H., & Stanway, G. (2009) · Journal of General Virology · doi:10.1099/vir.0.008813-0 · Cited by 55
“Several diagnostic laboratories now screen for HPeV infection and together with the retrospective analysis of archived material, a growing number of HPeV associations with disease have been reported recently (Baumgarte et al., 2008; Benschop et al., 2006a, 2008b; Boivin et al., 2005; De Souza Luna et al., 2008; De Vri…”
BackgroundJanes, V. A., Minnaar, R. P., Koen, G., van Eijk, H. W. M., de Haan, K., Pajkrt, D., Wolthers, K. C., & Benschop, K. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.46.20964 · Cited by 54
“Nowadays, RT-PCR targeting the conserved 5’UTR is the standard method for detection followed by sequencing of the capsid genes, in particular VP1, for typing [4,8,12,13].”
BackgroundMethodSelf-citationRooting human parechovirus evolution in time
Faria, N. R., de Vries, M., van Hemert, F. J., Benschop, K., & van der Hoek, L. (2009) · BMC Evolutionary Biology · doi:10.1186/1471-2148-9-164 · Cited by 53
“HPeV3 was first described in 2004 [6] and is associated with more severe conditions related to CNS symptoms [10,11,13].”
Self-citationLiu, B., Forman, M., & Valsamakis, A. (2019) · Journal of Virological Methods · doi:10.1016/j.jviromet.2019.113690 · Cited by 52
譲原佐栄子, Tanaka, F., Kai, S., Ao, K., Kikuchi, N., Hara, T., Mori, M., & Yokota, S. (2012) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-012-0420-9 · Cited by 51
“[6, 8, 9].”
BackgroundBennett, S., Harvala, H., Witteveldt, J., McWilliam Leitch, E. C., McLeish, N., Templeton, K., Gunson, R., Carman, W. F., & Simmonds, P. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02445-10 · Cited by 48
“More recently, separate real-time RT-PCR assays for the detection of EV and HPeV have been developed (3, 7, 17, 19, 20); the rapid molecular testing provided by these assays for hospitalized children is important, since it has been shown to reduce antibiotic usage, unnecessary investigations, and duration of hospital…”
BackgroundMethodInfluentialNanotechnological strategies for systemic microbial infections treatment: A review
Ramos, M. A. D. S., dos Santos, K. C., da Silva, P. B., de Toledo, L. G., Marena, G. D., Rodero, C. F., de Camargo, B. A. F., Fortunato, G. C., Bauab, T. M., & Chorilli, M. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119780 · Cited by 52
“also enteroviruses are the most common viral causes of sepsis worldwide specially in neonatal patients (Pinninti and Kimberlin, 2018), in addition, the enteroviruses and human parechoviruses are the most common causes of systemic infections in young (Wolthers et al., 2008).”
Vollbach, S., Müller, A., Drexler, J. F., Simon, A., Drosten, C., Eis-Hübinger, A. M., & Panning, M. (2015) · Virology Journal · doi:10.1186/s12985-015-0427-9 · Cited by 49
“sepsis-like illness in children worldwide [1–3].”
Gupta, N., Richter, R. P., Robert, S., & Kong, M. Y. F. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2018.00252 · Cited by 57
“HPeV3 is associated with more severe disease than HPeV1 (113).”
Backgroundde Jong, E. P., van den Beuken, M. G. A., van Elzakker, E. P. M., Wolthers, K. C., Sprij, A. J., Lopriore, E., Walther, F. J., & Brus, F. (2018) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001718 · Cited by 48
Self-citationHuman Parechovirus Central Nervous System Infections in Southern California Children
Felsenstein, S., Yang, S., Eubanks, N., Sobrera, E., Grimm, J. P., & Aldrovandi, G. (2014) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000112 · Cited by 48
“CNS disease caused by hPeV in infants appears to be primarily associated with hPeV type 3.(6,41,42) Interestingly, hPeV type 3 elicits a weaker neutralizing antibody response and shows faster replication in neural cells than type 1, possibly explaining the association of this subtype with CNS infections in young infan…”
BackgroundHuman parechoviruses in infants with systemic infection
Piñeiro, L., Vicente, D., Montes, M., Hernández‐Dorronsoro, U., & Cilla, G. (2010) · Journal of Medical Virology · doi:10.1002/jmv.21878 · Cited by 47
“Although most of the HPeV3 isolates in CSF reported to date correspond to children with sepsis-like illness [Wolthers et al., 2008; Harvala et al., 2009], as in our series, cases of neonatal meningoencephalitis with white matter injury have also been reported, sometimes with neurological sequelae…”
BackgroundResultInfluentialShakeel, S., Westerhuis, B. M., Domanska, A., Koning, R. I., Matadeen, R., Koster, A. J., Bakker, A. Q., Beaumont, T., Wolthers, K. C., & Butcher, S. J. (2016) · Nature Communications · doi:10.1038/ncomms11387 · Cited by 47
Self-citationvan Hinsbergh, T. M. T., Elbers, R. G., Ket, J. C. F., van Furth, A. M., & Obihara, C. C. (2020) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(20)30181-4 · Cited by 49
Zhong, H., Lin, Y., Sun, J., Su, L., Cao, L., Yang, Y., & Xu, J. (2011) · Journal of Medical Virology · doi:10.1002/jmv.22114 · Cited by 48
“…young children [Ito et al., 2004; Boivin et al., 2005; Abed and Boivin, 2006; Benschop et al., 2006a; Watanabe et al., 2007; de Vries et al., 2008; Wolthers et al., 2008; Harvala et al., 2009; Lev- Grant sponsor: National Key Technologies R&D Program of China (during the 11th 5-Year Plan Period);…”
BackgroundParechovirus Genotype 3 Outbreak among Infants, New South Wales, Australia, 2013–2014
Cumming, G., Khatami, A., McMullan, B. J., Musto, J., Leung, K., Nguyen, O. T. K., Ferson, M. J., Papadakis, G., & Sheppeard, V. K. (2015) · Emerging infectious diseases · doi:10.3201/eid2107.141149 · Cited by 45
“17%) in the NSW outbreak than in other outbreaks (8).”
BackgroundResultInfluentialHarvala, H., Benschop, K., Berginc, N., Midgley, S., Wolthers, K. C., Peter Simmonds, K., Feeney, S. A., Bailly, J., Mirand, A., & Fischer, T. K. (2021) · Microorganisms · doi:10.3390/microorganisms9091827 · Cited by 43
“Type 3 PeVs have been most frequently associated with severe disease such as sepsis-like illness and meningitis in neonates and infants [5,6,9,10].”
BackgroundSelf-citationThe need for treatment against human parechoviruses: how, why and when?
Wildenbeest, J., Harvala, H., Pajkrt, D., & Wolthers, K. C. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.130 · Cited by 52
Self-citationIntroduction of a novel parechovirus RT-PCR clinical test in a regional medical center
Renaud, C., Kuypers, J., Ficken, E., Cent, A., Corey, L., & Englund, J. A. (2011) · Journal of Clinical Virology · doi:10.1016/j.jcv.2011.02.010 · Cited by 40
Fatal neonatal parechovirus encephalitis
van Zwol, A. L., Lequin, M. H., Aarts-Tesselaar, C., van der Eijk, A. A., Driessen, G. J. A., de Hoog, M., & Govaert, P. P. (2009) · BMJ Case Reports · doi:10.1136/bcr.05.2009.1883 · Cited by 40
Amarnath, C., Mary, T. H., Periakarupan, A., Gopinathan, K., & Philson, J. (2015) · European Journal of Radiology · doi:10.1016/j.ejrad.2015.11.038 · Cited by 40
Human Parechovirus 3 in Infants: Expanding Our Knowledge of Adverse Outcomes
Joseph, L. J., May, M., Thomas, M., Smerdon, C., Tozer, S. J., Bialasiewicz, S., McKenna, R., Sargent, P. H., Kynaston, A., Heney, C., et al. (2018) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002136 · Cited by 39
Selvaraju, S. B., Nix, W. A., Oberste, M. S., & Selvarangan, R. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.01982-12 · Cited by 38
“It has been reported that HPeV molecular methods increased the CSF viral detection rate by 31% in a Dutch clinical center (5) and by 63% in 2007 and 122% in 2009 in our experience (4, 24) in cases of neonatal sepsis-like illness and meningitis in young children.”
BackgroundNiesters, H. G. M., Rossen, J. W. A., van der Avoort, H., Baas, D. C., Benschop, K., Claas, E. C. J., Kroneman, A., van Maarseveen, N. M., Pas, S. D., van Pelt, W., et al. (2013) · Eurosurveillance · doi:10.2807/ese.18.04.20387-en · Cited by 41
Self-citationHuman Parechovirus Infections Associated with Seizures and Rash in Infants and Toddlers
Karsch, K., Obermeier, P., Seeber, L., Chen, X., Tief, F., Mühlhans, S., Hoppe, C., Conrad, T., Böttcher, S., Diedrich, S., et al. (2015) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000802 · Cited by 36
“Others have suggested a biannual cycle for type HPeV-3.(31,32) Well-coordinated international surveillance efforts are needed to increase sample size and our understanding of the prevalence of different HPeV types in different seasons and geographic regions.”
BackgroundHuman parechovirus type 3 central nervous system infections in Israeli infants
Ghanem‐Zoubi, N., Shiner, M., Shulman, L. M., Sofer, D., Wolf, D. G., Marva, E., Kra-Oz, Z., Shachor‐Meyouhas, Y., Averbuch, D., Fellner, A., et al. (2013) · Journal of Clinical Virology · doi:10.1016/j.jcv.2013.06.001 · Cited by 37
Cheng, Z., Yang, J., Xia, H., Qiu, Y., Wang, Z., Han, Y., Xia, X., Qin, C., Hu, Y., & Zhou, X. (2013) · Journal of Virology · doi:10.1128/jvi.00245-13 · Cited by 37
“Picorna-like viruses in the Picornavirales order include numerous important pathogens that are responsible for diseases in humans, such as poliomyelitis (2), hand-foot-andmouth disease (3), hepatitis A (4), upper respiratory illness (5), myocarditis (6), diseases in insects, such as sacbrood (7), and diseases in plant…”
BackgroundDetection of enterovirus RNA in cerebrospinal fluid: Comparison of two molecular assays
de Crom, S. C. M., Obihara, C. C., van Loon, A. M., Argilagos-Alvarez, A. A., Peeters, M. F., van Furth, A. M., & Rossen, J. W. A. (2011) · Journal of Virological Methods · doi:10.1016/j.jviromet.2011.10.007 · Cited by 37
Asymptomatic children might transmit human parechovirus type 3 to neonates and young infants
Aizawa, Y., Yamanaka, T., Watanabe, K., Oishi, T., & Saitoh, A. (2015) · Journal of Clinical Virology · doi:10.1016/j.jcv.2015.07.300 · Cited by 36
Seroepidemiology of human parechovirus types 1, 3, and 6 in Yamagata, Japan, in 2014
Tanaka, S., Aoki, Y., Matoba, Y., Yahagi, K., Itagaki, T., Matsuzaki, Y., & Mizuta, K. (2016) · Microbiology and Immunology · doi:10.1111/1348-0421.12456 · Cited by 36
Identification of Potential Recombination Breakpoints in Human Parechoviruses
Zoll, J., Galama, J. M. D., & van Kuppeveld, F. J. M. (2009) · Journal of Virology · doi:10.1128/jvi.02529-08 · Cited by 36
“Parechovirus is a widespread pathogen associated with mild gastroenteritis and respiratory symptoms but is also a major cause of viral sepsis and meningitis in young children (31).”
BackgroundRole of toll-like receptor-mediated pyroptosis in sepsis-induced cardiomyopathy
Fan, Y., Guan, B., Xu, J., Zhang, H., Liang, Y., & Yang, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115493 · Cited by 36
Messacar, K., Breazeale, G., Wei, Q., Robinson, C. C., & Dominguez, S. R. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24119 · Cited by 34
“HPeVs have been implicated in cases of fever [Harvala et al., 2009], sepsis [Selvarangan et al., 2011], and CNS infection [Verboon-Maciolek et al., 2008; Wolthers et al., 2008; Felsenstein et al., 2014] in children, particularly in infants less than 6 months of age.”
BackgroundSevere Human Parechovirus Infections in Infants and the Role of Older Siblings
Nielsen, N. M., Midgley, S., Nielsen, A. C. Y., Christiansen, C. B., & Fischer, T. K. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kwv206 · Cited by 34
Enteroviruses and Parechoviruses
Stellrecht, K. A., Lamson, D. M., & Romero, J. R. (2011) · Wiley eBooks · doi:10.1128/9781555816728.ch85 · Cited by 35
Al‐Qahtani, S. M., Shati, A. A., Alqahtani, Y. A., & Ali, A. S. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.923125 · Cited by 37
“HPeV-3 represents the primary type of HPeVs causing PVM (35, 36).”
Backgroundde Crom, S. C. M., Rossen, J. W. A., de Moor, R. A., Veldkamp, E., van Furth, A. M., & Obihara, C. C. (2016) · Journal of Clinical Virology · doi:10.1016/j.jcv.2016.01.014 · Cited by 32
Chakrabarti, P., Warren, C., Vincent, L., & Kumar, Y. (2018) · European Journal of Pediatrics · doi:10.1007/s00431-018-3209-8 · Cited by 31
Human parechovirus-3 infection in children, South Korea
Han, T.-H., Chung, J.-Y., You, S. J., Youn, J.-L., & Shim, G.-H. (2013) · Journal of Clinical Virology · doi:10.1016/j.jcv.2013.05.023 · Cited by 30
Human picornaviruses associated with neurological diseases and their neutralization by antibodies
Anastasina, M., Domanska, A., Palm, K., & Butcher, S. J. (2017) · Journal of General Virology · doi:10.1099/jgv.0.000780 · Cited by 32
“269 It can cause systemic infections with possible neurological involvement in infants that 270 are collectively described as “sepsis-like illnesses” (Benschop et al., 2006; 271 Selvarangan et al., 2011; Wolthers et al., 2008).”
BackgroundInfluentialHara, S., Kawada, J., Kawano, Y., Yamashita, T., Minagawa, H., Okumura, N., & Ito, Y. (2013) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2013.11.002 · Cited by 31
Detection of human parechoviruses in children with gastroenteritis in South Korea
Han, T.-H., Kim, C.-H., Park, S., Chung, J., & Hwang, E. (2011) · Archives of Virology · doi:10.1007/s00705-011-0995-y · Cited by 30
Seo, J.-H., Yeom, J. S., Youn, H.-S., Han, T.-H., & Chung, J.-Y. (2015) · Korean Journal of Pediatrics · doi:10.3345/kjp.2015.58.3.102 · Cited by 29
Genomic features and evolutionary constraints in Saffold-like cardioviruses
Drexler, J. F., Baumgarte, S., Luna, L. K. D. S., Stöcker, A., de Almeida, P. S., Ribeiro, T. C. M., Petersen, N., Herzog, P., Pedroso, C., Brites, C. R., et al. (2010) · Journal of General Virology · doi:10.1099/vir.0.018887-0 · Cited by 29
Westerhuis, B. M., Jonker, S. C., Mattao, S., Benschop, K., & Wolthers, K. C. (2013) · Virology Journal · doi:10.1186/1743-422x-10-146 · Cited by 28
“HPeVs are associated with a wide range of clinical manifestations ranging from gastrointestinal and respiratory symptoms to more severe symptoms like central nervous system (CNS) infections and neonatal sepsis [1-4].”
Self-citationClinical relevance of positive human parechovirus type 1 and 3 PCR in stool samples
Wildenbeest, J., Wildenbeest, J., Benschop, K., Minnaar, R. P., Jongh, S. B.-D., Wolthers, K. C., Pajkrt, D., Benschop, K. S. M., Minnaar, R. P., Jongh, S. B.-D., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12542 · Cited by 27
“Human parechovirus (HPeV) is increasingly recognized as an important cause of sepsis-like illness (SLI) and meningitis in young children [1,2].”
BackgroundSelf-citationGuo, Y., Duan, Z., & Qian, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068321 · Cited by 27
“Some recent studies have indicated that additional PCR screening for HPeV has increased the detection of a potential viral cause of specific illnesses [6,7,9,32].”
BackgroundSevere human parechovirus sepsis beyond the neonatal period
Sainato, R. J., Flanagan, R., Mahlen, S. D., Fairchok, M. P., & Braun, L. E. (2011) · Journal of Clinical Virology · doi:10.1016/j.jcv.2011.02.009 · Cited by 27
“6 The epidemiology of disease with HPeV-3 is not yet well defined.”
Human Parechovirus Type 3 and 4 Associated With Severe Infections in Young Children
Kolehmainen, P., Jääskeläinen, A. J., Blomqvist, S., Kallio‐Kokko, H., Nuolivirta, K., Helminen, M., Roivainen, M., Lappalainen, M., & Tauriainen, S. (2014) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000401 · Cited by 26
“Detection of picornaviruses is in many clinical laboratories limited to EVs.”
ResultGargano, S., Fortuna, D., Nix, W. A., Bhatti, T. R., Wiley, C. A., Flanders, A. E., Urtecho, J. S., Sloane, J., Ahmad, J., & Curtis, M. T. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2015.05.008 · Cited by 26
Bangalore, H., Ahmed, J., Bible, J., Menson, E., Durward, A., & Tong, C. Y. W. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318207691c · Cited by 26
Tang, J. W.-T., Holmes, C. W., Elsanousi, F., Patel, A., Adam, F., Speight, R., Shenoy, S., Bronnert, D., Stiefel, G., Sundaram, P., et al. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.34.30326 · Cited by 25
“Infections with HPeV in neonates and infants have been well-documented [5-10], but HPeV has only relatively recently been included as a target in our in-house and some commercial PCR assays used for testing CSF.”
MethodAhmad, S., Dalwai, A., & Al‐Nakib, W. (2013) · Journal of Medical Virology · doi:10.1002/jmv.23604 · Cited by 25
“DOI 10.1002/jmv young infants [Verboon-Maciolek et al., 2008; Wolthers et al., 2008; Harvala et al., 2009, 2011; Pineiro et al., 2010; Walters et al., 2011].”
BackgroundInfluentialAcute and chronic disease caused by enteroviruses
Tang, J. W.-T., & Holmes, C. W. (2017) · Virulence · doi:10.1080/21505594.2017.1308620 · Cited by 27
Human Parechovirus Infection in Neonatal Intensive Care
Davis, J. W., Fairley, D., Christie, S. N., Coyle, P. V., Tubman, R. J., & Shields, M. D. (2014) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000510 · Cited by 24
“Ongoing surveillance is require to determine the true incidence of this infection and to determine whether it is a significant burden of disease.(11,30)”
BackgroundBubba, L., Martinelli, M., Pellegrinelli, L., Prímache, V., Tanzi, E., Pariani, E., & Binda, S. (2016) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001344 · Cited by 24
Metadata
- Authors
- Wolthers, K. C., Benschop, K. S. M., Schinkel, J., Molenkamp, R., Bergevoet, R. M., Spijkerman, I. J. B., Kraakman, H. C., & Pajkrt, D.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- OLVG (NL)
- Corresponding author
- Wolthers, Katja C.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-08
- Volume
- 47
- Issue
- 3
- Pages
- 358-363
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2166778219
- Cited by
- 252
- References
- 31
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 10 · 2023: 10 · 2022: 5 · 2021: 10 · 2020: 10 · 2019: 13 · 2018: 14 · 2017: 17 · 2016: 18 · 2015: 23 · 2014: 21 · 2013: 21 · 2012: 19
- FWCI
- 12.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and Maternal Infections
- Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
- Keywords
- human parechovirus, viral meningitis, enterovirus, cerebrospinal fluid, young children, virus detection, PCR detection, prevalence, neonatal sepsis, central nervous system infection
- MeSH terms
- Child, Preschool, Female, Humans, Infant, Infant, Newborn, Male, Meningitis, Viral, Netherlands, Picornaviridae Infections, Retrospective Studies, Seasons, Cohort Studies, Prevalence, Polymerase Chain Reaction, Sepsis, Parechovirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.